---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-101393"
form_type: "8-K"
ticker: "RYTM"
cik: "0001649904"
company_name: "RHYTHM PHARMACEUTICALS, INC."
filed_at: "2024-09-19T23:59:59+00:00"
generated_at: "2026-05-31T03:38:06.438845+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Rhythm Pharma shareholders elect three directors, approve equity plan at annual meeting

## Summary
- Elected Class I directors: Stuart Arbuckle (45.6M for), Christophe Jean (45.0M), Lynn Tetrault (45.5M).
- Ratified Ernst & Young as auditor: 53.8M for, 69.5K against.
- Advisory vote on executive compensation: 50.6M for, 1.5M against.
- Reapproved 2017 Equity Incentive Plan: 32.7M for, 19.4M against (63% of votes cast).

## SEC filing metadata
- accession: 0001104659-24-101393
- form_type: 8-K
- ticker: RYTM
- cik: 0001649904
- company_name: RHYTHM PHARMACEUTICALS, INC.
- filed_at: 2024-09-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649904/000110465924101393/0001104659-24-101393-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649904/000110465924101393/tm2424430d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-101393
- JSON: https://secwatch.observer/filing/0001104659-24-101393.json
- Plain text: https://secwatch.observer/filing/0001104659-24-101393.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.